Diabetic Neuropathie
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants were selected from a specialized outpatient service and regarded as suitable to participate in this study if they fulfilled the following criteria: clinical diagnoses of diabetic polyneuropathy; aged from 18 to 60 years; not lactating; no history of brain surgery, tumor, or intracranial metal implantation
Exclusion criteria
Exclusion criteria: Participants with any uncontrolled clinical disease, such as thyroid disease, cardiovascular, pulmonary, haematological or renal disease; alcohol or other substance abuse; pregnancy; lactation; neuropsychiatric disorders; history of epilepsy and metallic implants in the head were excluded. Patients with significant cognitive dysfunction were excluded. Patients were carefully evaluated by a physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in quality of life in the active M1 group, evaluated through the SF-36 questionnaire, by increasing the score of this questionnaire;Functionality improvement in active M1 group, verified through the SF-36 questionnaire, by increasing the score of this questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain improvement in active M1 group, verified through the pain scale in the SF-36 questionnaire, from the verification of a 3 point decrease in the pain scale for a favorable clinical outcome | — |
Countries
Brazil
Contacts
Universidade federal do rio grande do norte